MLYS compared with SPRY: revenue, margins and what each company keeps, and the suppliers and customers both name

MLYSMineralys Therapeutics, Inc.

Mkt capRevenueRevenue

SPRYARS Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

MLYSMineralys Therapeutics, Inc.

SPRYARS Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

MLYSwithSPRY

Uncorrelated: r 0.09 · 500D.

Shared co-movers1with MLYSwith SPRY

INFQInfleqtion, Inc.r 0.31r 0.28

MLYS, solidSPRY, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

MLYSMineralys Therapeutics, Inc.

15.52· pre 15.23· delayed

Mkt cap$1.4BRevenue—Revenue—

SPRYARS Pharmaceuticals, Inc.

3.03· pre 3.05· delayed

Pre-marketNov 3 '26delayed

Mkt cap$336.1MRevenue$34MQ2 FY26Revenue$84MFY25

Compare

Pre-marketNov 3 '26delayed

MLYSMineralys Therapeutics, Inc.

SPRYARS Pharmaceuticals, Inc.

15.52pre 15.23delayed

Price

3.03pre 3.05delayed

$1.4B

Mkt cap

$336.1M

—

Revenue

$34MQ2 FY26

—

Revenue

$84MFY25

MLYS15.52vsSPRY3.03Pre-marketNov 3 '26delayed